Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Printer Friendly Page BioNews RSS feed

Login



Will Fletcher

Will Fletcher

Will Fletcher is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its internship scheme. He studied Mathematics at University College London (UCL), then went on to acquire an MSc in Theoretical Physics at King's College London and an MRes in Modelling Biological Complexity at UCL's Centre for Mathematics and Physics in the Life Sciences and Experimental Biology. He is currently studying for a PhD in Computational Statistics in Molecular Phylogenetics at UCL's Research Department of Genetics, Evolution and Environment. He is also a Quantitative Analyst at the football betting consultancy Smartodds, and he has been a Fellow at the Parliamentary Office of Science and Technology. He is particularly interested in cutting-edge genetic research, and the advances in medical treatment that it makes possible.

 


BioNews Comment articles written by Will Fletcher:



No Articles for this area at the moment.


BioNews Review articles written by Will Fletcher:



No Articles for this area at the moment.


BioNews News articles written by Will Fletcher:

First pagePrevious page 1/5 Next pageLast page     10 per page20 per page50 per page100 per page

High-fibre diets may affect fertility

08 February 2010 - by Will Fletcher

Women who eat too much fibre may ovulate less and have lower oestrogen levels, according to a recent study...[Read More]

First non-embryonic stem cell product launched

21 December 2009 - by Will Fletcher

A commercial product claiming to be the first to make use of iPS (induced pluripotent stem) cell cells has been launched, albeit not a product that can be directly used on humans. Cellular Dynamics International (CDI), a biotech company based in Madison, Wisconsin, US, has recently announced that it has released human heart cells derived from iPS cells for commercial use. CDI intends its trademarked iCell Cardiomyocytes to be used by pharmaceutical companies to aid in the drug...[Read More]

Scientists take major step towards personalised childhood vaccines

07 December 2009 - by Will Fletcher

In the future children could be given 'personalised' vaccine shots if they are found to be in the genetic minority pf people who don't benefit fully from standard forms of a vaccine. Not everyone produces the same amount of disease specific antibodies in response to a vaccine, meaning that a vaccination will not protect some people when they later come into contact with that disease. However, scientists from the National Institute for Occupational Safety and Health (NIOSH), Morgantown, West V...[Read More]

Thousands of genomes sequenced to map Han Chinese genetic variation

30 November 2009 - by Will Fletcher

The first genetic historical map of the Han Chinese has been published in the American Journal of Human Genetics by scientists from the Genome Institute of Singapore (GIS). Based on genome-wide variation in 8,200 individuals, the new map has provided many insights into the evolutionary history and population structure of the Han Chinese which is the largest ethnic population in the world. The map is of great importance as it has helped uncover subtle differences in the genetic ...[Read More]

New drug could help treat Down's syndrome

23 November 2009 - by Will Fletcher

A new drug that is being developed may lessen the effects of learning difficulties caused by the genetic condition Down's syndrome. Children with the condition are not developmentally delayed at birth, but often fall behind as they grow older because of memory deficits. A new study in mice, published in the journal Science Translational Medicine, has identified the key brain defects responsible and has pointed out a strategy for dealing with them through medication. The US resea...[Read More]

Gene discovery hints at why humans can talk

16 November 2009 - by Will Fletcher

Scientists believe that they have found a gene that helps explain the fact that humans are the only animal that has developed speech. Subtle variations in the human version of the gene, known as FOXP2, appear to underpin the human development of language, according to recent research carried out by scientists at the University of California, Los Angeles (UCLA), US, and published in the journal Nature. When comparing the human and chimp version of FOXP2 the researchers discovered...[Read More]

UK considers plans to expand newborn screening programme

09 November 2009 - by Will Fletcher

The UK National Screening Committee is considering plans to screen newborn babies for a greater number of rare conditions. Currently, on a newborn's fifth day, a single spot of blood is taken from their heel, and they are screened for five conditions including sickle-cell disorders (SCD) and cystic fibrosis (CF). Parents then receive the results of the tests around eight weeks later. This lags behind some areas of Europe where they test for 10 or more conditions, and some American states that...[Read More]

Relaxation helps the success of IVF

26 October 2009 - by Will Fletcher

Reducing stress may increase fertility, a new study suggests. At a fertility centre in Boston, US, some women took part in a stress management program in parallel with their IVF (in vitro fertilisation) treatment whilst others did not. It was found that the program had no effect on how many women conceived at the first try. However, women who failed at the first attempt and were trying to get pregnant a second time, whilst using the stress management techniques,experienced a 160...[Read More]

Revealed at last: the epigenome

19 October 2009 - by Will Fletcher

The first detailed map of the human epigenome has been published. The epigenome, sometimes described as the 'instruction manual' to the human genome, is a regulatory network of chemical switches that governs the activation of human genes, and is therefore ultimately responsible for how a person grows and develops. Scientists believe that this exciting work could lead to new treatments for a range of illnesses including mental conditions such as schizophrenia, and l...[Read More]

Vaccine made from stem cells may help prevent colon cancer

12 October 2009 - by Will Fletcher

Stem cells could potentially be used to vaccinate people against colon cancer. This surprising conclusion was made by researchers from China and the US after laboratory mice immunised with human embryonic stem (ES) cells experienced a dramatic decline in tumour growth compared to control mice. The idea that embryonic material may generate an anti-tumour response is an old one, but one that has never been tested outside animal research, so to find such an effect wit...[Read More]

First pagePrevious page 1/5 Next pageLast page     10 per page20 per page50 per page100 per page




 

 

Advertise your products and services HERE - click for further details

Donate now, powered by Charity Choice

Good Fundraising Code


Supported by:

Wellcome Trust

Department
of Health

BioNews is published by:
Progress Educational Trust
www.progress.org.uk

Advertising & sponsorship
Terms & conditions
Sitemap

BioNews, c/o Progress Educational Trust, 140 Grays Inn Road, London WC1X 8AX, UK
Tel: +44 (0)20 7278 7870 Email:
Registered charity number 1011897

Website developed and built by Face to Face
Website designed by Thunder
Website technology by Ultimate Database


© 1999, 2010
BioNews